Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VCYTthis companyVeracyte, Inc.	$25.91	50.12×	2.53×	6.4×	33.31×	-24.0%	69.6%	14.3%	12.8%	5.1%	5.3%	3.8%	0.03×	-3.6×	0×	8.15×	0.0%	7	24.96	3	B+
BDSXBiodesix, Inc.	$7.92	-1.46×	-20.83×	0.58×	-4.79×	-1313.6%	81.1%	-31.4%	-39.8%	1430.6%	-38.9%	-46.1%	-29.56×	-2.45×	-3.6×	1.86×	0.0%	4	-5.55	1	D+
BIAFbioAffinity Technologies, Inc.	$2.65	-0.14×	0.28×	0.33×	0.23×	-141990.8%	23.2%	-171.6%	-242.0%	-204.9%	-125.3%	-462.3%	0.16×	0.37×	-238.27×	2.6×	0.0%	3	-16.55	2	C
BLLNBillionToOne, Inc.	$113.55	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
CSTLCastle Biosciences, Inc.	$32.57	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
GHGuardant Health, Inc.	$157.35	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
Peer median	—	-1.46×	0.28×	3.28×	0.23×	-640.8%	68.3%	-31.4%	-39.8%	1.6%	-25.1%	-1.8%	0.08×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	—